From: Stock Gumshoe<travis@stockgumshoe.com>
Subject: Stock Gumshoe Weekend Update
Preheader: What teasers and blatheration did you miss in the week that was?
Reply: travis@stockgumshoe.com
Please unsubscribe if you don't want Stock Gumshoe emails. 
If this message is not clearly formatted in your email, click here for the web version

WEEKEND UPDATE
December 17, 2017
Dear Valued Reader,

Another week of newsletter promises has come and gone... didja miss anything in between panics and elation over tax cuts, or between the frenzied screams about bitcoin?  Let's catch you up...

The most-discussed piece of the week was Michael Robinson's pitch about an "ADC" mandate that will make millions of truckers buy a particular little safety device from his top-secret company... did you see that one?  There is, as usual, just a little truth behind the hype, click below to...


Do NOT…

I repeat… Do NOT buy Bitcoin before you see what I’m revealing here.

This could be your only chance of turning $100 into a retirement fortune.

But you must act before February 2…

Or you’ll miss out on the best opportunity of your lifetime. Click here for details.


Advertisement

These newsletter ads that promise "government payouts" or "extra Social Security" or other "free" money probably generate more questions (and complaints) than even the "get rich quick" spiels about the next hot gold miner or biotech breakthrough/  And you can see why -- the target audience for investment newsletters is "folks in their 60s and 70s", for the most part, and the complexity of Social Security often makes people feel like they might be doing something wrong... so what's the story with this pitch from Personal Finance?   Thinkolator answers here.

I continue to get lots of questions about the ads for Paul Mampilly's "#1 stock for 2018", so we shared that solution with you this week as well, dear readers -- the Irregulars saw this piece about five weeks ago, but now I've posted the teaser solution for everyone.  What's this "Greatest Medical Breakthrough in History" stock?  Just click here for that story.

We also took a gander at a "tiny biotech" that Jason Stutman says controls the gene-editing future in agriculture that will stave off famine... our explanation of that spiel is here.

And the Irregulars got a double-dose of commentary this week as well -- Dr. KSS shared his latest thoughts on Aptose here, and I posted my Friday File, as usual, with lots of big picture thoughts and portfolio updates to go along with another teaser solution about the "next Amazon."


Disclaimer: Nothing in this email or in the linked articles should be considered to be individual investment advice -- we can't tell you what you should do with your money, we can just share our opinions and perspective. Our authors try to use reliable information sources but also make mistakes of both fact and judgement on occasion, so all assertions should be checked and confirmed. You should speak with your financial advisor and understand everything fully before committing money to any investment.

Most issues of this email newsletter include advertising, and it should not be assumed that the presence of an advertisement means that the product or service advertised is endorsed by Stock Gumshoe or the author. For full disclaimers, disclosure information, and privacy policies please see the prominent links at the bottom of each page at StockGumshoe.com.

If you wish to unsubscribe to these mailings, there are links at both the bottom and top of this email that you can use to do so permanently and safely, we have no wish to email people who don't want to receive these messages. Please note that unsubscribing using the link below applies only to receiving emails, if you are a member of the Stock Gumshoe Irregulars that membership will not automatically change or be canceled. Please contact us if you need to change a paid membership.
Unsubscribe
Stock Gumshoe, 351 Pleasant St., Suite B #205, Northampton, MA 01060